Search / Trial NCT06233708

Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant

Launched by ASAN MEDICAL CENTER · Jan 28, 2024

Trial Information

Current as of October 08, 2024

Completed

Keywords

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Adult patients
  • * Underwent liver transplantation for treating hepatocellular carcinoma
  • * Between Jan. 2008 - May. 2022
  • Exclusion Criteria:
  • * Pediatric patients (Age under 18 years)
  • * Re-transplantation
  • * Multi-organ transplantation

About Asan Medical Center

Asan Medical Center, located in Seoul, South Korea, is a leading healthcare institution renowned for its commitment to advanced medical research and patient care. With a focus on innovative clinical trials, the center aims to enhance healthcare outcomes through rigorous scientific investigation and collaboration. Asan Medical Center is equipped with state-of-the-art facilities and a multidisciplinary team of experts dedicated to exploring new therapeutic approaches across various medical fields. Its robust infrastructure supports a wide range of clinical studies, contributing significantly to the global medical community's understanding of diseases and treatment efficacy.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0